CYP19A1 and neoplasm: The antiproliferative effect of CDCA on Leydig cells was partly due to the inhibition of estrogen-dependent cell growth, which confirmed that the FXR agonist is a negative regulator of aromatase in testis stromal tumor cell lines [11].